Wellcome can sell Zovirax over counter
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.WELLCOME has won approval to sell its highly successful Zovirax anti-herpes product direct to the British public, writes Gail Counsell.
Zovirax is effective against a number of conditions including shingles and genital herpes. But Wellcome will only be allowed to promote it direct to the public for the treatment of cold sores.
The company said yesterday the necessary formalities were expected to be completed shortly and it hoped to have Zovirax Cold Sore Cream available at chemists from mid-July.
Last year total sales of Zovirax were worth around pounds 586m to Wellcome, of which about pounds 70m related to sales for the treatment of cold sores. These were mostly European as the product is not approved for the treatment of cold sores in the US.
'At the moment doctors do not tend to prescribe it for cold sores - probably on grounds of cost,' Nigel Barnes, an analyst with brokers Hoare Govett, said.
'But it is the only really effective product against this virus and the potential demand is considerable. Taking it over the counter could be very big.'
He estimated that sales could triple to more than pounds 200m once the cream was approved for over-the-counter sale throughout Europe.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments